Recurrent Ovarian Germ Cell Tumor Terminated Phase 1 Trials for Fludeoxyglucose (18F) (DB09502)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01494012Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian CancerTreatment